Atul Gawande: 'This historic price reduction will broaden access to this life-saving drug and keep us on the path to end TB by 2030'

The Stop TB Partnership said on Aug. 30 that its Global Drug Facility (GDF) has initiated price reductions of up to 55% on bedaquiline, a vital medication used in the treatment of drug-resistant tuberculosis (DR-TB).